(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Significant Milestone for Li Auto; Oculis and Lucid Group Price Equity Offering: Latest Updates and Trading Figures

June 01st, 2023

Li Auto Inc. (Nasdaq: LI), a Chinese electric vehicle manufacturer, announced that it achieved a remarkable milestone in May 2023 by delivering 28,277 vehicles, representing a 146.0% year-over-year increase.  Xiang Li, Chairman and CEO of Li . Read more

President Biden Applauds House Passage of Bipartisan Budget Agreement, Calls for Swift Senate Approval

June 01st, 2023

In a statement released yesterday, President Joe Biden expressed his appreciation for the House of Representatives' passage of the Bipartisan Budget Agreement, emphasizing its significance in averting a potential default and preserving the nation's h. Read more

Analysts See Upside: Bullish Projections for Cedar Fair, Colliers, MasterCraft, SeaWorld, Sovos Brands and TIM S.A.

June 01st, 2023

Cedar Fair, L.P. (NYSE: FUN), a leading operator of amusement parks and water parks, has been initiated with a Buy rating by Goldman Sachs, with a price target of $50.  $FUN closed at $44.62 on Wednesday, indicating a potential upside of $5.3. Read more

Pfizer's RSV Vaccine Approval, Victoria's Secret Misses Estimates, nCino and PVH Surpass Expectations: Stock Market Recap

June 01st, 2023

Pfizer Inc. (NYSE: PFE), a global pharmaceutical company specializing in vaccines and medicines, announced that its bivalent RSV prefusion F (RSVpreF) vaccine, ABRYSVO, has received approval from the U.S. Food and Drug Administration (FDA).  . Read more

Xylem, Liberty Latin America, Saga Communications, Telefonica Brasil, Terns Pharma, NICE: Analyst Ratings and Price Targets Hint at Potential Upsides

June 01st, 2023

Xylem Inc. (NYSE: XYL) has received an upgrade from Neutral to Outperform by Robert W. Baird, with the price target raised from $122 to $135.  On Wednesday, $XYL closed at $100.20, indicating a potential upside of $34.80 or 34.72% based on th. Read more

Promising Findings from HOOKIPA's HPV16+ Head and Neck Cancer Study; Chewy Beats Estimates, C3.ai Revenue Outlook Disappoints

June 01st, 2023

HOOKIPA Pharma Inc. (Nasdaq: HOOK) has released promising preliminary data from its Phase 2 study of HB-200 in combination with pembrolizumab, offering hope for patients with recurrent/metastatic Human Papillomavirus 16-positive (HPV16+) head and nec. Read more

FTC and DOJ Charge Amazon with Violating Children’s Privacy Law by Keeping Kids’ Alexa Voice Recordings Forever and Undermining Parents’ Deletion Requests

May 31st, 2023

Proposed order to require Amazon to pay $25 million and delete children’s data, geolocation data, and other voice recordings Washington D.C. / CRWE PRESS RELEASE / May 31, 2023  -  The Federal Trade Commission and the Department of. Read more

Chevron, Nevro, America Movil, Hillman Solutions, Grupo Televisa, and ACNB - Assessing Potential Upside and Price Targets

May 31st, 2023

Chevron Corporation (NYSE: CVX), a multinational energy corporation, has been upgraded from Underweight to Neutral by JP Morgan. The price target for $CVX has also been raised from $161 to $170 based on the firm's view.  On Wednesday, $CVX cl. Read more

Akebia Therapeutics, MDxHealth, Avis Budget, argenx, Five9, Inventiva: Analyst Upgrades and Initiations Point to Potential Upsides

May 31st, 2023

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company, received an upgrade from Neutral to Overweight by Piper Sandler, with the price target raised from $2 to $4.  On Wednesday, $AKBA closed at $1.04, indicating a potential u. Read more

Better-Than-Expected Results: Nordstrom and NetApp Thrive, Okta and Salesforce Encounter Market Headwinds

May 31st, 2023

Nordstrom, Inc. (NYSE: JWN), a renowned fashion retailer with a presence in the United States and Canada, reported first quarter 2023 adjusted earnings per share (EPS) of $0.07, surpassing the consensus estimate of a loss of $0.08 per share.  . Read more